Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)

SHA:603363 Revenue

Fujian Aonong Biological Technology Group Incorporation had revenue of 2.21B CNY in the quarter ending March 31, 2026, with 23.71% growth. This brings the company's revenue in the last twelve months to 8.90B, up 9.33% year-over-year. In the year 2025, Fujian Aonong Biological Technology Group Incorporation had annual revenue of 8.47B, down -3.29%.

• Revenue (ttm): 8.90B
• Revenue Growth: +9.33%
• P/S Ratio: 0.87
• Revenue / Employee: 1.74M
• Employees: 5,126
• Market Cap: 7.76B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.47B	-287.93M	-3.29%
Dec 31, 2024	8.76B	-10.69B	-54.97%
Dec 31, 2023	19.46B	-2.16B	-9.97%
Dec 31, 2022	21.61B	3.57B	19.82%
Dec 31, 2021	18.04B	6.52B	56.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error